OBJECTIVES
Tricuspid regurgitation (TR) is associated with high morbidity and mortality. The TricValve bicaval valve system has emerged as a transcatheter option for patients with severe symptomatic TR who are not candidates for surgery or orthotopic interventions. However, its safety in patients with pre-existing card...
K. Osipenko, Iuliana Coti, Paul Werner et al.· European Journal of Cardio-T...· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
Using direct ambulatory intracardiac LAP monitoring, consistent diurnal variation with higher evening pressures was observed, largely unchanged by diuretic dose or dosing schedule, atrial fibrillation, or association with ADHF events.
Yuval Amir, A. Shaul, O. Koren et al.· European Journal of Heart Fa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.